Author Correction: Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells
- PMID: 40140907
- PMCID: PMC11938680
- DOI: 10.1186/s13059-025-03548-z
Author Correction: Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells
Erratum for
-
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.Genome Biol. 2023 Apr 24;24(1):89. doi: 10.1186/s13059-023-02928-7. Genome Biol. 2023. PMID: 37095570 Free PMC article.
Similar articles
-
Combining different CRISPR nucleases for simultaneous knock-in and base editing prevents translocations in multiplex-edited CAR T cells.Genome Biol. 2023 Apr 24;24(1):89. doi: 10.1186/s13059-023-02928-7. Genome Biol. 2023. PMID: 37095570 Free PMC article.
-
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors.Nat Commun. 2019 Nov 19;10(1):5222. doi: 10.1038/s41467-019-13007-6. Nat Commun. 2019. PMID: 31745080 Free PMC article.
-
An aptamer-mediated base editing platform for simultaneous knockin and multiple gene knockout for allogeneic CAR-T cells generation.Mol Ther. 2024 Aug 7;32(8):2692-2710. doi: 10.1016/j.ymthe.2024.06.033. Epub 2024 Jun 26. Mol Ther. 2024. PMID: 38937969 Free PMC article.
-
Use of CRISPR/Cas9 gene editing to improve chimeric antigen-receptor T cell therapy: A systematic review and meta-analysis of preclinical studies.Cytotherapy. 2022 Apr;24(4):405-412. doi: 10.1016/j.jcyt.2021.10.010. Epub 2022 Jan 14. Cytotherapy. 2022. PMID: 35039239
-
Unleashing the Therapeutic Potential of CAR-T Cell Therapy Using Gene-Editing Technologies.Mol Cells. 2018 Aug 31;41(8):717-723. doi: 10.14348/molcells.2018.0242. Epub 2018 Aug 14. Mol Cells. 2018. PMID: 30110720 Free PMC article. Review.
References
-
- Gaudelli NM, Lam DK, Rees H, et al. Directed evolution of adenine base editors with increased activity and therapeutic application. Nat Biotechnol. 2020;38:7. 10.1038/s41587-020-0491-6. - PubMed
Publication types
LinkOut - more resources
Full Text Sources